May 04, 2020 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the 9 Meters Biopharma Transaction Conference Call to discuss the closing of the mergers between Innovate Biopharmaceuticals, RDD Pharma and Naia Rare Diseases. (Operator Instructions) I would also like to remind you that this call is being recorded for replay and can be accessed on the Events and Presentations section of our Investor page at www.9meters.com.
I'll now turn the call over to Edward Sitar, CFO of 9 Meters. Please go ahead, sir.
Edward J. Sitar - 9 Meters Biopharma, Inc. - CFO
Good morning, everyone. We're thrilled you're joining us this morning. Last Thursday evening, we announced the completion of the merger of Innovate Biopharmaceuticals and RDD creating 9 Meters Biopharma. At 9:30 this morning, 9 Meters will begin trading on NASDAQ under the new ticker NMTR. Our call today will share with you some of the details of our new company.
Before we begin, I'd like to remind everyone that this conference call may include forward-looking statements. Each
Innovate Biopharmaceuticals, Inc., RDD Pharma, Ltd. - M&A Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot